Trial: 201912077

A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 Antitrypsin (AAT) Combined with Corticosteroids vs. Corticosteroids Alone for the Treatment of High Risk Acute Graft-versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplant

Phase

III

Principal Investigator

Schroeder, Mark

Disease Site

Acute Lymphocytic Leukemia (ALL); Acute Myeloid Leukemia (AML); Chronic Lymphocytic Leukemia (CLL); Chronic Myeloid Leukemia (CML); Lymphoid Leukemia; Myeloid and Monocytic Leukemia; Non-Hodgkin’s Lymphoma

Learn more about this study at: clinicaltrials.gov